Segal Trials

June marks Men's Health Month, an annual observance aimed at heightening awareness of preventable health issues and promoting early detection and treatment of disease among men and boys. More than ever, the focus is shifting beyond mere physical wellness, incorporating mental and overall well-being.

The second blog in the series about schizophrenia, tells the story of a young woman whose life took an unforeseen turn when she began experiencing symptoms of schizophrenia.

Join us as we delve into the world of schizophrenia and gain a deeper understanding of how it affects lives. Whether you or someone you know has been diagnosed with schizophrenia, or you simply want to learn more about this condition, this series is for you.

Welcome to our Blog Series about Schizophrenia! Schizophrenia is a complex and often misunderstood mental health condition that affects millions of people around the world. Despite its prevalence, many people still hold misconceptions about schizophrenia and the people who live with it.

This series of blogs explores the realities of schizophrenia, dispelling common myths, and providing information and resources to those who need it. Whether you or someone you know has been diagnosed with schizophrenia, or you simply want to learn more about this condition, this series is for you.

Migraines affect about 12% worldwide and are more common in women than men. If you struggle with migraines a clinical study could help.

Psychedelics have been used for centuries in spiritual and medicinal settings, but only recently have they begun to gain acceptance in the scientific community. Research on psychedelics such as LSD, psilocybin, and MDMA is expanding rapidly, with promising findings in treatments for mental health disorders like depression, anxiety, and PTSD, to name a few. 

Clinical research is how all treatments reach patients, including medications to treat mental illnesses. All medications currently on the market went through the rigorous stages of the clinical research funnel, and many more are currently being researched. To date, Segal Trials has 57 medications and devices that are approved by the U.S. Food and Drug Administration (FDA). That’s 57 treatments changing the lives of millions of patients. 

Clinical studies found psychedelic drugs such as lysergic acid diethylamide (LSD) may be effective at reducing symptoms of anxiety, learn the facts.

Our focus for 2023 is to raise mental health awareness and to keep a stream of constant communication flowing. 

Raising mental health awareness is an important social issue that needs to be addressed. Conversations encourage people to talk about mental health issues and to know it's completely normal to seek help - if needed. Mental health awareness also helps to reduce the stigma associated with seeking mental health services. When we talk about mental health, we create an environment where people feel safe and supported to talk about their mental health, allowing easier access to services and a better understanding of the needs of individuals experiencing mental health issues.